Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.65 |
| ▸ | NOD1 | Q9Y239 | 8/20 | 0.56 |
| ▸ | CTSL | P07711 | 1/20 | 0.54 |
| ▸ | NMT2 | O60551 | 2/20 | 0.53 |
| ▸ | NMT1 | P30419 | 2/20 | 0.53 |
| ▸ | TLR2 | O60603 | 2/20 | 0.51 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | FURIN | P09958 | 1/20 | 0.46 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.46 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1673186 | 0.95 | SLC6A5 (0.58) | SLC6A5NOD1CTSLNMT2NMT1 | |
| SCHEMBL1673194 | 0.95 | SLC6A5 (0.58) | SLC6A5NOD1CTSLNMT2NMT1 | |
| SCHEMBL30399641 | 0.95 | SLC6A5 (0.58) | SLC6A5NOD1CTSLNMT2NMT1 | |
| SCHEMBL30905802 | 0.95 | SLC6A5 (0.58) | SLC6A5NOD1CTSLNMT2NMT1 | |
| SCHEMBL352420 | 0.95 | SLC6A5 (0.58) | SLC6A5NOD1CTSLNMT2NMT1 | |
| SCHEMBL1280087 | 0.95 | SLC6A5 (0.58) | SLC6A5NOD1CTSLNMT2NMT1 | |
| SCHEMBL31307652 | 0.94 | SLC6A5 (0.57) | SLC6A5NOD1CTSLNMT2NMT1 | |
| SCHEMBL31307621 | 0.94 | SLC6A5 (0.57) | SLC6A5NOD1CTSLNMT2NMT1 | |
| SCHEMBL31307627 | 0.94 | SLC6A5 (0.57) | SLC6A5NOD1CTSLNMT2NMT1 | |
| SCHEMBL31307648 | 0.94 | SLC6A5 (0.57) | SLC6A5NOD1CTSLNMT2NMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023156070-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | disclosed |
| WO-2023156071-A1 | KIT OF COSMETIC COMPOSITIONS | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | disclosed |
| WO-2023156069-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | disclosed |
| WO-2013155146-A2 | SKIN EXFOLIATION DEVICES AND KITS | THE PROCTER & GAMBLE COMPANY (US) | 2013-10-17 | — | — | WO | disclosed |
| EP-1809139-A2 | TREATMENT ARTICLES CAPABLE OF CONFORMING TO AN UNDERLYING SHAPE | The Procter and Gamble Company (US) | 2007-07-25 | — | — | EP | disclosed |
| WO-2006053332-A2 | TREATMENT ARTICLES CAPABLE OF CONFORMING TO AN UNDERLYING SHAPE | THE PROCTER & GAMBLE COMPANY (US) | 2006-05-18 | — | — | WO | disclosed |
| EP-1499285-A2 | TOPICAL USE OF VITAMIN B6 COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-26 | — | — | EP | disclosed |
| WO-2003082230-A2 | TOPICAL USE OF VITAMIN B6 COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-09 | — | — | WO | disclosed |
| EP-1171090-A2 | METHODS FOR REGULATING THE CONDITION OF MAMMALIAN KERATINOUS TISSUE | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000062742-A2 | METHODS FOR REGULATING THE CONDITION OF MAMMALIAN KERATINOUS TISSUE | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |